Communicating mild cognitive impairment diagnoses with and without amyloid imaging.

TitleCommunicating mild cognitive impairment diagnoses with and without amyloid imaging.
Publication TypeJournal Article
Year of Publication2017
AuthorsGrill, J. D., Apostolova, L. G., Bullain, S., Burns, J. M., Cox, C. G., Dick, M., Hartley, D., Kawas, C., Kremen, S., Lingler, J., Lopez, O. L., Mapstone, M., Pierce, A., Rabinovici, G., Roberts, J. S., Sajjadi, S. A., Teng, E., & Karlawish, J.
JournalAlzheimer's research & therapy
Volume9
Issue1
Pagination35
Date Published2017 May 04
ISSN1758-9193
Abstract

Mild cognitive impairment (MCI) has an uncertain etiology and prognosis and may be challenging for clinicians to discuss with patients and families. Amyloid imaging may aid specialists in determining MCI etiology and prognosis, but creates novel challenges related to disease labeling.

DOI10.1186/s13195-017-0261-y
Alternate JournalAlzheimers Res Ther